Author:
Jung S.,Sehouli J.,Chekerov R.,Kluschke F.,Patzelt A.,Fuss H.,Knorr F.,Lademann J.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Degen A, Alter M, Schenck F, Satzger I, Volker B, Kapp A, Gutzmer R (2010) The hand-foot-syndrome associated with medical tumor therapy—classification and management. J Dtsch Dermatol Ges 8:652–661
2. Lassere Y, Hoff P (2004) Management of hand-foot syndrome in patients treated with capecitabine (Xeloda). Eur J Oncol Nurs 8(Suppl 1):S31–S40
3. Lipworth AD, Robert C, Zhu AX (2009) Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib. Oncology 77:257–271
4. Nagore E, Insa A, Sanmartin O (2000) Antineoplastic therapy-induced palmar plantar erythrodysesthesia (‘hand-foot’) syndrome. Incidence, recognition and management. Am J Clin Dermatol 1:225–234
5. Webster-Gandy JD, How C, Harrold K (2007) Palmar–plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre. Eur J Oncol Nurs 11:238–246
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献